Program Committee
-
Yuji Kumagai, MD, PhD Professor, Kitasato Clinical Research Center
Kitasato University Hospital, Japan -
Keiichi Inaizumi, MSc Clinical Study Innovation Lead, Clinical Project Management Group
Pfizer R&D Japan, Japan -
Taro Amagasaki, PhD Head, Analytics Japan
Novartis Pharma K.K., Japan -
Nobuyuki Hanamura, PhD, MBA Senior Director, Clinical Operations
IQVIA, Japan -
Toshiko Ishibashi, PhD, RN Oncology Medical Science Department, Medical Affairs Division
Daiichi Sankyo Co., Ltd., Japan -
Kazuhiko Ishida, MSc, RPh Director, Pharmacovigilance
Astellas Pharma Inc., Japan -
Yayoi Kitawaki, MS Department Head, Neuroscience, GTx Development Unit
Novartis Pharma K.K., Japan -
Yoshiko Komuro, PhD Inspection Director, Office of Non-Clinical and Clinical Compliance
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Takashi Moriya, PhD, MBA Senior Director, Medical Affairs
Edwards Lifesciences, Japan -
Sumimasa Nagai, MD, PhD Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan -
Shinichi Nishiuma, MD Senior medical director
Jazz pharmaceuticals Japan, Japan -
Mika Ogasawara Data Quality Lead, Biometrics and Data Management
Pfizer R&D Japan G.K., Japan -
Goshi Ozawa, MS CEO
Real Discovery Outdorrs K.K., Japan -
Keiko Tsumori, MSc Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
MSD K.K., Japan -
Junichi Nishino, MSc, RPh Head, Regulatory Affairs Department
Otsuka Pharmaceutical Co., Ltd., Japan -
Hironobu Saito, PhD Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan -
Junko Sato, PhD Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Takashi Sato, MSc, PMP
PM Orchestra Takashi Sato, Japan -
Atsushi Tsukamoto, PhD, MSc Head is Therapeutic Area Strategies
Daiichi Sankyo, United States
Have an account?